{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:42:17Z","timestamp":1753602137306,"version":"3.37.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:00:00Z","timestamp":1653177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T00:00:00Z","timestamp":1653177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Posterior uveitis represents the second most frequent type of uveitis (15\u201330% of all uveitis). Noninfectious posterior uveitis complicated with secondary cystoid macular edema (CME) affects the visual prognosis negatively. The objective of the current study is to detect possible microvascular changes causing relapsing uveitis-related CME using optical coherence tomography angiography (OCTA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is an interventional, observational, retrospective study with 1\u00a0year follow-up. Patients with noninfectious, posterior uveitis-related CME undergoing dexamethasone (DEX) implant were evaluated. Following the DEX-implant were carried out control visits after 1\u00a0month, 2-months, 4-months, 6-months, and for up 1-year. A total of 76 eyes of 38 consecutive patients with noninfectious posterior uveitis were enrolled (consecutive sample). Complicated noninfectious posterior uveitis with secondary CME was diagnosed in 56 eyes of uveitis patients (73.7%) and reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our investigation showed (1) a reduction in superficial vessel plexus (SVP) measurements within 2-month (84%), reaching 96.4% for up 1-year, (2) an irregular profile of SVP in 69.6% of cases, persisting for up 1-year; relapsing uveitis-related CME eyes with irregular superficial foveal avascular zone (FAZ) profile were in 51%, while the SVP measurements reestablished in 100% of cases. Conversely, (3) the deep vascular plexus (DVP) parameters restored in a lower number of eyes within the 2-month (39.3%), remaining abnormal in 46.4% of cases for up 1-year; despite DVP restored in 53.6% of cases for up 1\u00a0year, (4) a capillary rarefaction ring around the FAZ appeared in 80.4% of cases; the relapsing uveitis-related CME eyes with abnormal DVP parameters were present in 41% of cases, of which 92.1% showed a rarefaction ring had abnormal DVP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The use of OCTA enabled the evaluation in detail of retinal microvascular changes. We suggested that the possibility of the recurrence of the uveitis-related CME depends on the persistence of modifications of the superficial and deep layers. In this regard, we propose to implement the current imaging armamentarium with OCTA for the follow-up of patients with noninfectious uveitis-related CME.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10792-022-02327-0","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T12:02:25Z","timestamp":1653220945000},"page":"3285-3293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6193-3299","authenticated-orcid":false,"given":"Valeria","family":"Albano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Furino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Sborgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Sborgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Boscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,22]]},"reference":[{"issue":"1","key":"2327_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","volume":"26","author":"T Tsirouki","year":"2018","unstructured":"Tsirouki T, Dastiridou A, Symeonidis C et al (2018) A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 26(1):2\u201316","journal-title":"Ocul Immunol Inflamm"},{"key":"2327_CR2","doi-asserted-by":"crossref","unstructured":"Uy HS, Yu-Keh E, Chan PS (2015) Posterior uveitis. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, Do DV (eds) Developments in ophthalmology. S. Karger AG [cited 2020 Dec 8], pp 163\u2013166. Available from: https:\/\/www.karger.com\/Article\/FullText\/438968","DOI":"10.1159\/000438968"},{"key":"2327_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","volume":"189","author":"JV Forrester","year":"2018","unstructured":"Forrester JV, Kuffova L, Dick AD (2018) Autoimmunity, autoinflammation, and infection in uveitis. Am J Ophthalmol 189:77\u201385","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2327_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0301-4738.58470","volume":"58","author":"J Biswas","year":"2010","unstructured":"Biswas J, Sudharshan S, Ganesh S (2010) Current approach in the diagnosis and management of posterior uveitis. Indian J Ophthalmol 58(1):29","journal-title":"Indian J Ophthalmol"},{"issue":"1\u20132","key":"2327_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40123-014-0023-x","volume":"3","author":"C Castiblanco","year":"2014","unstructured":"Castiblanco C, Foster CS (2014) Review of systemic immunosuppression for autoimmune uveitis. Ophthalmol Ther 3(1\u20132):17\u201336","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"2327_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","volume":"113","author":"CWTA Lardenoye","year":"2006","unstructured":"Lardenoye CWTA, van Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113(8):1446\u20131449","journal-title":"Ophthalmology"},{"issue":"7","key":"2327_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.18240\/ijo.2019.07.23","volume":"12","author":"Y-R Chung","year":"2019","unstructured":"Chung Y-R (2019) Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 12(7):1202\u20131208","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"2327_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000081203","volume":"36","author":"A Bringmann","year":"2004","unstructured":"Bringmann A, Reichenbach A, Wiedemann P (2004) Pathomechanisms of cystoid macular edema. Ophthalmic Res 36(5):241\u2013249","journal-title":"Ophthalmic Res"},{"issue":"4","key":"2327_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09273940802187466","volume":"16","author":"L Iannetti","year":"2008","unstructured":"Iannetti L, Accorinti M, Liverani M, Caggiano C, Abdulaziz R, Pivetti-Pezzi P (2008) Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. Ocul Immunol Inflamm 16(4):155\u2013160","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"2327_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1076\/ocii.11.1.29.15582","volume":"11","author":"N Okhravi","year":"2003","unstructured":"Okhravi N, Lightman S (2003) Cystoid macular edema in uveitis. Ocul Immunol Inflamm 11(1):29\u201338","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"2327_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10792-013-9822-7","volume":"34","author":"S Onal","year":"2014","unstructured":"Onal S, Tugal-Tutkun I, Neri P, Herbort C (2014) Optical coherence tomography imaging in uveitis. Int Ophthalmol 34(2):401\u2013435","journal-title":"Int Ophthalmol"},{"key":"2327_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.preteyeres.2017.04.005","volume":"59","author":"F Pichi","year":"2017","unstructured":"Pichi F, Sarraf D, Arepalli S et al (2017) The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res 59:178\u2013201","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"2327_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1517\/14656566.2011.571209","volume":"12","author":"NV Saraiya","year":"2011","unstructured":"Saraiya NV, Goldstein DA (2011) Dexamethasone for ocular inflammation. Expert Opin Pharmacother 12(7):1127\u20131131","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"2327_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13063-020-4066-0","volume":"21","author":"C Couret","year":"2020","unstructured":"Couret C, Poinas A, Volteau C et al (2020) Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial. Trials 21(1):159","journal-title":"Trials"},{"issue":"8","key":"2327_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/IAE.0000000000000515","volume":"35","author":"RN Khurana","year":"2015","unstructured":"Khurana RN, Porco TC (2015) Efficacy and safety of dexamethasone intravitreal implant for persistent uveitic cystoid macular edema. Retina 35(8):1640\u20131646","journal-title":"Retina"},{"issue":"9","key":"2327_CR16","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/ceo.13694","volume":"47","author":"DN Ong","year":"2019","unstructured":"Ong DN, Lim LL (2019) The efficacy of intravitreal dexamethasone implants for non-infectious posterior segment uveitis: increasing the uveitis armamentarium. Clin Exp Ophthalmol 47(9):1119\u20131121","journal-title":"Clin Exp Ophthalmol"},{"issue":"68","key":"2327_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21680","volume":"21","author":"H Squires","year":"2017","unstructured":"Squires H, Poku E, Bermejo I et al (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Health Technol Assess 21(68):1\u2013170","journal-title":"Health Technol Assess"},{"issue":"5","key":"2327_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4274\/tjo.galenos.2019.81594","volume":"49","author":"M Hasanreiso\u011flu","year":"2019","unstructured":"Hasanreiso\u011flu M, \u00d6zdemir HB, \u00d6zkan K et al (2019) Intravitreal dexamethasone implant in the treatment of non-infectious uveitis. Turk J Ophthalmol 49(5):250\u2013257","journal-title":"Turk J Ophthalmol"},{"issue":"1","key":"2327_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12348-018-0148-5","volume":"8","author":"MM Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez MM, Solano MM, Porco TC et al (2018) Epidemiology of uveitis in a US populationbased study. J Ophthalmic Inflamm Infect 8(1):6","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"5","key":"2327_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"C Lowder","year":"2011","unstructured":"Lowder C, Belfort R Jr, Lightman S et al (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129(5):9","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2327_CR21","first-page":"835","volume":"8","author":"YC Yap","year":"2015","unstructured":"Yap YC, Papathomas T, Kamal A (2015) Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex\u00ae) in non-infectious posterior uveitis. Int J Ophthalmol 8(4):835\u2013838","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"2327_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3109\/09273948.2016.1160130","volume":"25","author":"AC Tsang","year":"2017","unstructured":"Tsang AC, Virgili G, Abtahi M, Gottlieb CC (2017) Intravitreal dexamethasone implant for the treatment of macular edema in chronic non-infectious uveitis. Ocul Immunol Inflamm 25(5):690\u2013697","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"2327_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/jop.2016.0139","volume":"33","author":"A Fr\u00e8re","year":"2017","unstructured":"Fr\u00e8re A, Caspers L, Makhoul D et al (2017) Single dexamethasone intravitreal implant in the treatment of noninfectious uveitis. J Ocul Pharmacol Ther 33(4):290\u2013297","journal-title":"J Ocul Pharmacol Ther"},{"key":"2327_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2147\/OPTH.S84207","volume":"9","author":"S Ryder","year":"2015","unstructured":"Ryder S, Iannetta D, Bhaleeya S, Kiss S (2015) Efficacy and tolerability of bilateral sustainedrelease dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion. OPTH 9:1109","journal-title":"OPTH"},{"key":"2327_CR25","doi-asserted-by":"crossref","unstructured":"Shulman S, Azem N, Gepstein R (2017) Use of intravitreal dexamethasone implant (Ozurdex) prior to cataract surgery in uveitic patients. J Clin Exp Ophthalmol [cited 2021 Jan 6];08(05). Available from: https:\/\/www.omicsonline.org\/open-access\/use-of-intravitrealdexamethasone-implant-ozurdex-prior-to-cataract-surgery-in-uveitic-patients-2155-9570-1000680-93908.html 17","DOI":"10.4172\/2155-9570.1000680"},{"issue":"10","key":"2327_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.18240\/ijo.2019.10.11","volume":"12","author":"L Mastropasqua","year":"2019","unstructured":"Mastropasqua L, Di Staso S, D\u2019Aloisio R et al (2019) Anatomical and functional changes after dexamethasone implant and ranibizumab in diabetic macular edema: a retrospective cohort study. Int J Ophthalmol 12(10):1589\u20131597","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"2327_CR27","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG et al (2016) STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 6(11):e012799","journal-title":"BMJ Open"},{"key":"2327_CR28","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J et al (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710\u20134725","journal-title":"Opt Express"},{"issue":"3","key":"2327_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ceo.13470","volume":"47","author":"A Invernizzi","year":"2019","unstructured":"Invernizzi A, Cozzi M, Staurenghi G (2019) Optical coherence tomography and optical coherence tomography angiography in uveitis: a review. Clin Experiment Ophthalmol 47(3):357\u2013371","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"2327_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ophtha.2003.08.037","volume":"111","author":"NN Markomichelakis","year":"2004","unstructured":"Markomichelakis NN, Halkiadakis I, Pantelia E et al (2004) Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 111(5):946\u2013953","journal-title":"Ophthalmology"},{"issue":"4","key":"2327_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80(4):332\u2013336","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"2327_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/eye.2016.133","volume":"30","author":"RS Grajewski","year":"2016","unstructured":"Grajewski RS, Boelke AC, Adler W et al (2016) Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. Eye 30(11):1415\u20131423","journal-title":"Eye"},{"issue":"2","key":"2327_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09273940701244509","volume":"15","author":"NN Markomichelakis","year":"2007","unstructured":"Markomichelakis NN, Halkiadakis I, Pantelia E et al (2007) Course of macular edema in uveitis under medical treatment. Ocul Immunol Inflamm 15(2):71\u201379","journal-title":"Ocul Immunol Inflamm"},{"key":"2327_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000336676","volume":"51","author":"P LeHoang","year":"2012","unstructured":"LeHoang P (2012) The gold standard of noninfectious uveitis: corticosteroids. Dev Ophthalmol 51:7\u201328","journal-title":"Dev Ophthalmol"},{"issue":"5292","key":"2327_CR35","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/bmj.1.5292.1579","volume":"1","author":"BH Robinson","year":"1962","unstructured":"Robinson BH, Mattingly D, Cope CL (1962) Adrenal function after prolonged corticosteroid therapy. Br Med J 1(5292):1579\u20131584","journal-title":"Br Med J"},{"issue":"6","key":"2327_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/bjo.82.6.704","volume":"82","author":"RM Stanbury","year":"1998","unstructured":"Stanbury RM, Graham EM (1998) Systemic corticosteroid therapy\u2013side effects and their management. Br J Ophthalmol 82(6):704\u2013708","journal-title":"Br J Ophthalmol"},{"key":"2327_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ajo.2017.03.001","volume":"177","author":"C Fardeau","year":"2017","unstructured":"Fardeau C, Simon A, Rodde B et al (2017) Interferon-alpha2a and systemic corticosteroid in monotherapy in chronic uveitis: results of the randomized controlled BIRDFERON study. Am J Ophthalmol 177:182\u2013194","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2327_CR38","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s10067-016-3426-3","volume":"35","author":"C Fabiani","year":"2016","unstructured":"Fabiani C, Vitale A, Lopalco G, Iannone F, Frediani B, Cantarini L (2016) Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art. Clin Rheumatol 35(11):2631\u20132638","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2327_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10067-016-3480-x","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G et al (2017) Efficacy and safety of adalimumab in Beh\u00e7et\u2019s diseaserelated uveitis: a multicenter retrospective observational study. Clin Rheumatol 36(1):183\u2013189","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2327_CR40","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s10067-016-3527-z","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Sota J, Tosi GM et al (2017) The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. Clin Rheumatol 36(10):2307\u20132318","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2327_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G et al (2017) Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36(1):191\u2013197","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2327_CR42","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/eye.2016.115","volume":"30","author":"C Fardeau","year":"2016","unstructured":"Fardeau C, Champion E, Massamba N, LeHoang P (2016) Uveitic macular edema. Eye (Lond 30(10):1277\u20131292","journal-title":"Eye (Lond"},{"issue":"6","key":"2327_CR43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/ICU.0000000000000210","volume":"26","author":"C Fabiani","year":"2015","unstructured":"Fabiani C, Ali\u00f3 JL (2015) Local (topical and intraocular) therapy for ocular Adamantiades\u2212Beh\u00e7et\u02bcs disease. Curr Opin Ophthalmol 26(6):546\u2013552","journal-title":"Curr Opin Ophthalmol"},{"key":"2327_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ajo.2016.04.020","volume":"169","author":"H Hoerauf","year":"2016","unstructured":"Hoerauf H, Feltgen N, Weiss C et al (2016) Clinical efficacy and safety of ranibizumab versus dexamethasone for central retinal vein occlusion (COMRADE C): a European label study. Am J Ophthalmol 169:258\u2013267","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2327_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000368987","volume":"232","author":"U Pleyer","year":"2014","unstructured":"Pleyer U, Klamann M, Laurent T-J et al (2014) Fast and successful management of intraocular inflammation with a single intravitreal dexamethasone implant. Ophthalmologica 232(4):223\u2013229","journal-title":"Ophthalmologica"},{"issue":"4","key":"2327_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/09273948.2015.1132738","volume":"25","author":"J Nobre-Cardoso","year":"2017","unstructured":"Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B (2017) Treatment of non-infectious uveitic macular edema with the intravitreal dexamethasone implant. Ocul Immunol Inflamm 25(4):447\u2013454","journal-title":"Ocul Immunol Inflamm"},{"key":"2327_CR47","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2147\/OPTH.S40268","volume":"7","author":"R Karim","year":"2013","unstructured":"Karim R, Sykakis E, Lightman S, Fraserbell S (2013) Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. OPTH 7:1109","journal-title":"OPTH"},{"issue":"1","key":"2327_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/eye.2001.5","volume":"15","author":"G Freeman","year":"2001","unstructured":"Freeman G (2001) Cystoid macular oedema in uveitis: an unsolved problem. Eye 15(1):12\u201317","journal-title":"Eye"},{"issue":"9","key":"2327_CR49","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/archopht.1978.03910060294024","volume":"96","author":"EL Howes","year":"1978","unstructured":"Howes EL, Cruse VK (1978) The structural basis of altered vascular permeability following intraocular inflammation. Arch Ophthalmol 96(9):1668\u20131676","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2327_CR50","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2147\/OPTH.S4033","volume":"2","author":"TG Rotsos","year":"2008","unstructured":"Rotsos TG, Moschos MM (2008) Cystoid macular edema. Clin Ophthalmol 2(4):919\u2013930","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"2327_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/tjo.tjo_31_17","volume":"7","author":"A Hagag","year":"2017","unstructured":"Hagag A, Gao S, Jia Y, Huang D (2017) Optical coherence tomography angiography: technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol 7(3):115","journal-title":"Taiwan J Ophthalmol"},{"issue":"10","key":"2327_CR52","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s10792-019-01080-1","volume":"39","author":"S Emre","year":"2019","unstructured":"Emre S, G\u00fcven-Y\u0131lmaz S, Ulusoy MO, Ate\u015f H (2019) Optical coherence tomography angiography findings in Behcet patients. Int Ophthalmol 39(10):2391\u20132399","journal-title":"Int Ophthalmol"},{"issue":"1","key":"2327_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12348-019-0176-9","volume":"9","author":"VLS Dingerkus","year":"2019","unstructured":"Dingerkus VLS, Munk MR, Brinkmann MP et al (2019) Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis. J Ophthal Inflamm Infect 9(1):10","journal-title":"J Ophthal Inflamm Infect"},{"issue":"9","key":"2327_CR54","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/bjophthalmol-2018-313078","volume":"103","author":"M Tian","year":"2019","unstructured":"Tian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR (2019) Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol 103(9):1289\u20131295","journal-title":"Br J Ophthalmol"},{"key":"2327_CR55","doi-asserted-by":"publisher","first-page":"251584142091778","DOI":"10.1177\/2515841420917781","volume":"12","author":"A Marchese","year":"2020","unstructured":"Marchese A, Agarwal A, Moretti AG et al (2020) Advances in imaging of uveitis. Ophthalmol Eye Dis 12:251584142091778","journal-title":"Ophthalmol Eye Dis"},{"issue":"2","key":"2327_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/JOCO.JOCO_107_20","volume":"32","author":"S Khochtali","year":"2020","unstructured":"Khochtali S, Dridi T, Abroug N, Ksiaa I, Lupidi M, Khairallah M (2020) Swept-source optical coherence tomography angiography shows choriocapillaris flow reduction in multiple evanescent white dot syndrome. J Curr Ophthalmol 32(2):211\u2013215","journal-title":"J Curr Ophthalmol"},{"issue":"1","key":"2327_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12348-019-0190-y","volume":"9","author":"P Tranos","year":"2019","unstructured":"Tranos P, Karasavvidou E-M, Gkorou O, Pavesio C (2019) Optical coherence tomography angiography in uveitis. J Ophthal Inflamm Infect 9(1):21","journal-title":"J Ophthal Inflamm Infect"},{"issue":"4","key":"2327_CR58","first-page":"312","volume":"8","author":"O Karti","year":"2019","unstructured":"Karti O, Saatci AO (2019) Optical coherence tomography angiography in eyes with noninfectious posterior uveitis; some practical aspects. Med Hypothesis Discov Innov Ophthalmol 8(4):312\u2013322","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"9","key":"2327_CR59","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1097\/IAE.0000000000001418","volume":"37","author":"M Khairallah","year":"2017","unstructured":"Khairallah M, Abroug N, Khochtali S et al (2017) Optical coherence tomography angiography in patients with Beh\u00e7et uveitis. Retina 37(9):1678\u20131691","journal-title":"Retina"},{"issue":"10","key":"2327_CR60","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00417-018-4057-y","volume":"256","author":"M Waizel","year":"2018","unstructured":"Waizel M, Todorova MG, Terrada C, LeHoang P, Massamba N, Bodaghi B (2018) Superficial and deep retinal foveal avascular zone OCTA findings of non-infectious anterior and posterior uveitis. Graefes Arch Clin Exp Ophthalmol 256(10):1977\u20131984","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2327_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajo.2016.08.035","volume":"171","author":"AY Kim","year":"2016","unstructured":"Kim AY, Rodger DC, Shahidzadeh A et al (2016) Quantifying retinal microvascular changes in uveitis using spectral-domain optical coherence tomography angiography. Am J Ophthalmol 171:101\u2013112","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"2327_CR62","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.3390\/jcm9124087","volume":"9","author":"G Cennamo","year":"2020","unstructured":"Cennamo G, Montorio D, Santoro C et al (2020) The retinal vessel density as a new vascular biomarker in multisystem involvement in fabry disease: an optical coherence tomography angiography study. J Clin Med 9(12):4087","journal-title":"J Clin Med"},{"issue":"7","key":"2327_CR63","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00592-017-0996-8","volume":"54","author":"A Carnevali","year":"2017","unstructured":"Carnevali A, Sacconi R, Corbelli E et al (2017) Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol 54(7):695\u2013702","journal-title":"Acta Diabetol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02327-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02327-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02327-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T04:11:14Z","timestamp":1666498274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02327-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,22]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2327"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02327-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2022,5,22]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and approved by the institution\u2019s review board. Each patient signed the informed consent form. Consent for publication Written informed consent was obtained for publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}